+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
The Medicines Company - logo

The Medicines Company aims to be a leader in the areas of serious infectious disease care, acute cardiovascular care, and surgery and perioperative care. Its marketed products include Angiomax, an anticoagulant used during coronary angioplasties; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; and Ionsys for the short-term management of acute postoperative pain. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.

From
From
Bacterial Pneumonia - Pipeline Insight, 2024 - Product Thumbnail Image

Bacterial Pneumonia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cardiovascular Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 300 Pages
  • Global
From
Anti-Platelet Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Platelet Agents - Global Strategic Business Report

  • Report
  • November 2024
  • 94 Pages
  • Global
From
Acute Coronary Syndrome - Global Strategic Business Report - Product Thumbnail Image

Acute Coronary Syndrome - Global Strategic Business Report

  • Report
  • November 2024
  • 182 Pages
  • Global
From
MRSA Drugs - Global Strategic Business Report - Product Thumbnail Image

MRSA Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 183 Pages
  • Global
From
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Antibiotic Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Antibiotic Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 100 Pages
  • Global
From
Inclisiran - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Inclisiran - Emerging Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Asthma - Competitive landscape, 2023 - Product Thumbnail Image

Asthma - Competitive landscape, 2023

  • Report
  • April 2023
  • 240 Pages
  • Global
From
Sedation - Pipeline Insight, 2024 - Product Thumbnail Image

Sedation - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Glioma - Competitive Landscape, 2023 - Product Thumbnail Image

Glioma - Competitive Landscape, 2023

  • Report
  • April 2023
  • 450 Pages
  • Global
From
Peptide Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 192 Pages
  • Global
From
From
Critical Care Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Critical Care Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 280 Pages
  • Global
From
From
Vaginitis Therapeutics Global Market Report 2024 - Product Thumbnail Image

Vaginitis Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Loading Indicator